NCT02640989View on ClinicalTrials.gov

Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military

PHASE4CompletedINTERVENTIONAL
Enrollment

292

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

April 30, 2015

Conditions
Influenza
Interventions
BIOLOGICAL

Seasonal trivalent influenza vaccine, Anflu®

Seasonal trivalent influenza vaccine manufactured by Sinovac Co., Ltd.

BIOLOGICAL

Seasonal trivalent influenza vaccine, VAXIGRIP

Seasonal trivalent influenza vaccine manufactured by PasteurSanofi Pasteur

BIOLOGICAL

Seasonal trivalent influenza vaccine, Fluarix

Seasonal trivalent influenza vaccine manufactured by GlaxoSmithKline Biologicals

Trial Locations (1)

100042

Center for Disease Prevention and Control of Beijing Military Region, Beijing

All Listed Sponsors
lead

Center for Disease Prevention and Control of Beijing Military Region

OTHER

NCT02640989 - Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military | Biotech Hunter | Biotech Hunter